全球短期機械循環系統市場規模（按產品、治療方法、最終用戶、區域範圍和預測）

短期機械循環系統的市場規模及預測

2024 年短期機械循環系統市場規模價值 20.783 億美元，預計到 2032 年將達到 48.7299 億美元，在 2026-2032 年預測期內的複合年成長率為 11.24%。

推動全球短期機械循環系統市場的因素

短期機械循環系統市場的促進因素可能受到多種因素的影響。這些因素包括：

人口老化：隨著世界人口老化，心臟衰竭等心血管疾病的發生率不斷上升。老年人體質虛弱，如果有心臟問題，可能需要機械循環系統支持。

生活型態因素：心血管疾病（CVD）盛行率的上升是由於久坐不動的生活型態、不良飲食、吸菸和肥胖的增加，需要加強MCS等替代治療方法。

創新設備：醫療技術不斷發展，帶來更小、更容易插入且更有效率的 MCS 設備。這些發展正在擴大 MCS 在臨床實踐中的應用，並改善患者的治療效果。

提高安全性和耐用性：提高生物相容性、降低併發症發生率和延長設備壽命導致 MCS 設備的使用量迅速增加。

移植和復健的橋樑：對於患有終末期心臟衰竭的患者，MCS 設備是心臟移植的重要橋樑，同時還可在心血管手術或突發心臟危機後的恢復期間提供短期支持。

適應症不斷擴大：由於 MCS 的臨床適應症不斷擴大，包括心源性休克和高經皮經皮冠狀動脈介入治療 (PCI) 患者，市場也在不斷擴大。

醫療保健支出：成熟市場和新興市場的醫療保健支出不斷增加，推動了對 MCS 等尖端醫療技術的投資增加。

覆蓋範圍和報銷：改進的覆蓋範圍和報銷指南使患者更容易獲得 MCS 程序和設備。

支持監管核准和良好的法規環境：為了促進市場進入和成長，FDA 和 EMA 等監管機構正在為新的 MCS 設備提供更有效率的核准程序。

臨床研究和證據：臨床研究的積極結果和越來越多的臨床證據證明 MCS 設備的有效性，從而提高了醫生的信心和採用率。

市場動態：主要企業和競爭格局：創新和市場成長受到現有市場參與者對研發和策略夥伴關係的投資所推動。

全球擴張：滲透新市場和擴大分銷網路將增加市場潛力。

患者接受度和意識宣傳活動：加強向患者和醫療保健專業人員宣傳心臟衰竭治療和 MCS 選項，將提高採用率。

患者結果和生活品質：MCS 支持已被證明可以改善患者結果和生活品質，鼓勵接受和使用這些設備。

限制全球短期機械循環系統市場的因素

短期內，機械循環系統市場可能面臨多種限制或挑戰，包括：

設備成本：MCS 設備價格昂貴，且與設備相關的初始成本相當高。

營運成本：使用這些儀器的成本因使用這些儀器相關的營運成本而增加，例如消耗品、維護和對專業人員的需求。

醫療保健預算限制：許多醫療保健系統，尤其是低度開發國家，發現難以資助昂貴的 MCS 治療。

技術複雜性：MCS 設備的安裝和維護需要先進的醫療保健基礎設施和高素質的醫療專業人員。

對患者的風險：出血、感染和裝置相關併發症的高風險可能會阻止患者使用這些治療方法。

監管障礙：獲得新 MCS 設備的監管核准既費時又昂貴，而且不同地區的監管要求存在差異，這又增加了複雜性。

上市後監測：為了監測其設備的有效性和安全性，製造商必須進行徹底且通常耗費大量資源的上市後調查計畫。

保險範圍：MCS 療法費用昂貴，因此有些保險公司不願意承保，而且報銷規則各不相同。

報銷率：醫院和臨床醫生採用這些技術的意願可能會受到報銷率的影響，而報銷率（如果適用）可能不足以抵消這些成本。

缺乏知識：醫療保健專業人員可能沒有充分了解 MCS 設備的最新發展和優勢。

所需培訓：醫療保健專業人員必須接受大量培訓才能正確使用 MCS 設備，這在無法獲得專門培訓計劃的地區可能會很困難。

激烈的競爭：許多公司正在爭奪大量市場佔有率，這可能導致價格壓力和持續創新的需求。

科技進步迅速：科技的快速進步需要持續的研發投入，這對企業，尤其是中小企業帶來資金壓力。

經濟不確定性：醫療保健支出和對尖端醫療技術的投資可能會受到某些地區景氣衰退和金融不穩定的影響。

地緣政治不確定性：醫療設備市場和供應鏈動態可能會受到地緣政治變數的影響，例如貿易限制和政治不穩定。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

第4章 短期機械流通市場：依產品

• 主動脈內球囊幫浦（IABP）
• 經皮輔助人工心臟（pVAD）
• 體外膜氧氣療法（ECMO）
• 其他設備

第5章短期機械自行車市場：治療方法

• 心源性休克
• 急性心臟衰竭
• 術後支持

第6章 短期機械流通市場（依最終使用者）

• 醫院
• 門診手術中心
• 專科診所

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• Abiomed
• Medtronic
• SynCardia
• Berlin Heart GmbH
• CardiacAssist Inc.
• Jarvik Heart Inc.
• MicroMed Cardiovascular Inc.
• ReliantHeart Inc.
• Thoratec Corporation
• CHF Solutions

第11章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Short Term Mechanical Circulatory Market Size And Forecast

Short Term Mechanical Circulatory Market size was valued at USD 2078.3 Million in 2024 and is projected to reach USD 4872.99 Million by 2032, growing at a CAGR of 11.24% during the forecast period 2026-2032.

Global Short Term Mechanical Circulatory Market Drivers

The market drivers for the Short Term Mechanical Circulatory Market can be influenced by various factors. These may include:

Population Ageing: The prevalence of cardiovascular disorders, such as heart failure, is increasing as the world's population ages. Due to their increased vulnerability, older persons may need mechanical circulatory support if they have heart problems.

Lifestyle Factors: The increased incidence of CVDs is attributed to the rise of sedentary lifestyles, poor diets, smoking, and obesity, which calls for enhanced treatment alternatives like MCS.

Innovative Devices: Medical technology is constantly evolving, and this has resulted in the development of MCS devices that are smaller, less intrusive, and more effective. These developments increase the application of MCS in clinical settings and enhance patient outcomes.

Better Safety and Durability: MCS device usage has surged due to improved biocompatibility, lower complication rates, and longer-lasting devices.

Bridge to Transplant and Rehab: For patients with end-stage heart failure, MCS devices are an essential bridge to a heart transplant. Additionally, they offer short-term assistance while recovering from heart surgery or sudden cardiac crises.

Expanded Indications: The market is growing because to the growing list of clinical indications for MCS, which includes patients with cardiogenic shock and high-risk percutaneous coronary procedures (PCI).

Healthcare Spending: More money is being invested in cutting-edge medical technology, such as MCS, as a result of rising healthcare spending in both established and emerging markets.

Insurance Coverage and Reimbursement: Patients can now access MCS procedures and equipment more easily thanks to improved insurance coverage and reimbursement guidelines.

Regulatory Approvals and Support Good Regulatory Environment: To promote market entry and growth, regulatory organisations like the FDA and EMA are offering more efficient clearance procedures for novel MCS devices.

Clinical studies and Evidence: Physician confidence and adoption rates are increased by the positive results of clinical studies and the expanding body of clinical evidence demonstrating the effectiveness of MCS devices.

Market Dynamics: Key Players and Competitive Landscape: Innovation and market growth are propelled by the presence of well-established market players who invest in R&D and strategic alliances.

Global Reach: Market potential are improved by growing market penetration in new markets and enlarging distribution networks.

Campaigns to Increase Patient Acceptance and Awareness: Higher adoption rates are a result of increased efforts to educate patients and healthcare professionals about heart failure treatments and MCS choices.

Patient Outcomes and Quality of Life: Acceptance and usage of these devices are encouraged by shown improvements in patient outcomes and quality of life with MCS support.

Global Short Term Mechanical Circulatory Market Restraints

Several factors can act as restraints or challenges for the Short Term Mechanical Circulatory Market. These may include:

Cost of Device: MCS devices are costly, with significant up-front expenditures associated with the equipment.

Operational Costs: The cost of using these devices is increased by the operational costs related to their use, which include disposables, maintenance, and the requirement for specialised personnel.

Healthcare Budget Restraints: It might be difficult to allocate funds for pricey MCS therapy in many healthcare systems, particularly in underdeveloped nations.

Technical Complexity: Advanced healthcare infrastructure and highly qualified medical professionals are needed for the installation and maintenance of MCS devices.

Patient Risk: The use of these treatments may be discouraged due to the high risks involved, which include bleeding, infection, and complications related to the devices.

Regulatory Obstacles: It can take a while and be expensive to get regulatory approval for new MCS devices. The intricacy is increased by regional variations in regulatory requirements.

Post-Market Surveillance: To keep an eye on the effectiveness and safety of their devices, manufacturers must conduct a thorough, often resource-intensive, post-market surveillance programme.

Insurance Coverage: Due to the high expense of MCS therapies, several insurers are hesitant to pay for them. Reimbursement rules for these therapies might be uneven.

Reimbursement Rates: Hospital and clinician desire to embrace these technologies may be impacted by reimbursement rates, which, even in cases where they are covered, may not adequately offset the costs involved.

Lack of Knowledge: Healthcare professionals may not be fully informed about the most recent developments and advantages of MCS equipment.

Training Requirements: In order to use MCS devices properly, medical practitioners must undergo extensive training, which can be a challenge in areas with limited access to specialised training programmes.

Fierce Competition: A number of businesses are fighting for a larger part of the market. Pricing pressures and the requirement for ongoing innovation may result from this.

Fast Technological improvements: Investing continuously in R&D is necessary due to the rapid improvements in technology, and this can put a financial pressure on businesses, particularly smaller ones.

Economic Instability: Healthcare spending and investments in cutting-edge medical technologies may be impacted by economic downturns and financial instability in some areas.

Geopolitical Uncertainty: The dynamics of the MCS device market and supply chain may be impacted by geopolitical variables like as trade restrictions and political unrest.

Global Short Term Mechanical Circulatory Market Segmentation Analysis

The Global Short Term Mechanical Circulatory Market is Segmented on the basis of Product, Therapy, End-User, And Geography.

Short Term Mechanical Circulatory Market, By Product

• Intra-aortic Balloon Pumps (IABPs): These minimally invasive devices are inserted into the aorta, the main artery leaving the heart. A small balloon inflates and deflates with each heartbeat, helping to improve blood flow throughout the body and reduce workload on the heart. They are typically used for short-term support in patients experiencing cardiogenic shock or heart failure.
• Percutaneous Ventricular Assist Devices (pVADs): These compact pumps are inserted directly into the heart or a nearby blood vessel. They take over some or all of the heart's pumping function, providing temporary circulatory support. pVADs are used for a wider range of situations compared to IABPs, including bridge to transplant, bridge to decision (allowing time for further evaluation), and destination therapy (long-term support for patients ineligible for transplant).
• Extracorporeal Membrane Oxygenation (ECMO): This technique involves using a heart-lung bypass machine to provide temporary support for both the heart and lungs. Blood is removed from the body, oxygenated, and then returned, essentially taking over the function of these vital organs. ECMO is used in critically ill patients with severe respiratory or cardiac failure.
• Other Devices: This category includes emerging technologies and niche products within the short-term mechanical circulatory support market. Examples might be Impella devices (specialized pVADs) or ventricular unloading devices.

Short Term Mechanical Circulatory Market, By Therapy

• Cardiogenic Shock: This is a life-threatening condition where the heart is unable to pump enough blood to meet the body's needs. Short-term mechanical circulatory support plays a crucial role in stabilizing these patients and improving their chances of recovery.
• Acute Heart Failure: A sudden worsening of heart failure symptoms can necessitate temporary mechanical support to bridge patients to definitive treatment or recovery.
• Post-Operative Support: Following heart surgery, some patients may require short-term circulatory assistance to allow for proper healing and recovery.

Short Term Mechanical Circulatory Market, By End-User

• Hospitals: The primary users of short-term mechanical circulatory support devices are hospitals, particularly those with advanced cardiac care units and cardiothoracic surgery programs.
• Ambulatory Surgical Centers: In some cases, minimally invasive procedures using certain short-term circulatory support devices might be performed in ambulatory surgical centers.
• Specialty Clinics: Certain specialty clinics focusing on heart failure management or advanced heart conditions might utilize short-term circulatory support devices for specific procedures or patient needs.

Short Term Mechanical Circulatory Market, By Geography

• North America: Market conditions and demand in the United States, Canada, and Mexico.
• Europe: Analysis of the Short Term Mechanical Circulatory Market in European countries.
• Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa: Examining market dynamics in the Middle East and African regions.
• Latin America: Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Short Term Mechanical Circulatory Market are:
• Abiomed
• Medtronic
• SynCardia
• Berlin Heart GmbH
• CardiacAssist Inc.
• Jarvik Heart Inc.
• MicroMed Cardiovascular Inc.
• ReliantHeart Inc.
• Thoratec Corporation
• CHF Solutions

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Short Term Mechanical Circulatory Market, By Product

• Intra-aortic Balloon Pumps (IABPs)
• Percutaneous Ventricular Assist Devices (pVADs)
• Extracorporeal Membrane Oxygenation (ECMO)
• Other Devices

5. Short Term Mechanical Circulatory Market, By Therapy

• Cardiogenic Shock
• Acute Heart Failure
• Post-Operative Support

6. Short Term Mechanical Circulatory Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abiomed
• Medtronic
• SynCardia
• Berlin Heart GmbH
• CardiacAssist Inc.
• Jarvik Heart Inc.
• MicroMed Cardiovascular Inc.
• ReliantHeart Inc.
• Thoratec Corporation
• CHF Solutions

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References